| | | | | |
AMPH Amphastar Pharmaceuticals, Inc. | $20,1800 | -2,56% | $960,34M | $328,11K | |
REPL Replimune Group, Inc. | $11,0600 | -1,25% | $960,31M | $3,41M | |
| $56,1900 | -1,21% | $957,77M | $112,13K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | $28,0000 | +0,79% | $957,06M | $54,61K | |
AVTX Avalo Therapeutics, Inc. Common Stock | $18,4800 | -4,20% | $956,69M | $2,17M | |
HSLV Highlander Silver Corp. | $4,6600 | -2,31% | $956,09M | $284,71K | |
| $54,8800 | +1,26% | $955,17M | $60,82K | |
SANA Sana Biotechnology, Inc. Common Stock | $3,4800 | +0,87% | $951,75M | $2,03M | |
ABX Abacus Global Management, Inc. | $10,7100 | -0,37% | $950,59M | $609,22K | |
ANRO Alto Neuroscience Inc. | $26,3900 | -5,99% | $948,94M | $360,95K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | $2,8700 | +0,70% | $948,29M | $912,58K | |
RHLD Resolute Holdings Management, Inc. | $144,53 | +4,08% | $948,28M | $163,12K | |
BTZ BlackRock Credit Allocation Income Trust | $10,2200 | -0,29% | $948,17M | $321,87K | |
DBVT DBV Technologies S.A. | $16,3900 | +2,44% | $947,57M | $223,48K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | $13,6250 | +1,68% | $947,08M | $6,74K | |
